Boston

Boston Signs Out-License and Option Agreement with GSK to Advance Two Programs for Oncology and CNS Disorders

  • by

Shots: Boston will lead the development of selected programs through PoC. GSK gets an option to reacquire each program under pre-agreed terms for development and WW commercialization, after completion of POC studies If GSK exercises its repurchase option, Boston to receive a one-time payment and… Read More »Boston Signs Out-License and Option Agreement with GSK to Advance Two Programs for Oncology and CNS Disorders

Boston Signs Out-License and Option Agreement with GSK to Advance Two Programs for Oncology and CNS Disorders

  • by

Shots: Boston will lead the development of selected programs through PoC. GSK gets an option to reacquire each program under pre-agreed terms for development and WW commercialization, after completion of POC studies If GSK exercises its repurchase option, Boston to receive a one-time payment and… Read More »Boston Signs Out-License and Option Agreement with GSK to Advance Two Programs for Oncology and CNS Disorders

TEDMED 2020 Meetups

  • by

TEDMED Meetups, uniquely designed conversations, engage the entire TEDMED community to share their individual perspectives and voices to help improve humanity’s health. Read on to view some of the details of these captivating conversations taking place at TEDMED 2020. Meetup 1 Tuesday, March 3rd, 8:00… Read More »TEDMED 2020 Meetups